FDA Inspection 1301436 — University Of Texas MD Anderson Cancer Center: PET
The FDA completed an inspection of University Of Texas MD Anderson Cancer Center: PET on February 24, 2026 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 24, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Houston, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 17755 | 21 CFR 212.20(a) | Oversight of production operations |
| 17812 | 21 CFR 212.50 | Adequate controls (general) |
| 17835 | 21 CFR 212.50(c)(7) | ID of major equipment |
| 21376 | 21 CFR 212.30(a) | Orderly handling, prevention of mix-ups, prevention of contamination |